1.A Systematic Review of Economic Evaluation of Thyroid Cancer
Mijin KIM ; Woojin LIM ; Kyungsik KIM ; Ja Seong BAE ; Byung Joo LEE ; Bon Seok KOO ; Eun Kyung LEE ; Eu Jeong KU ; June Young CHOI ; Bo Hyun KIM ; Sue K. PARK
International Journal of Thyroidology 2022;15(2):74-104
		                        		
		                        			 Background:
		                        			This systematic review was conducted to identify and summarize key factors, including economic methods, topics, results, and indicators, within relevant economic evaluation research on thyroid cancer.  
		                        		
		                        			Materials and Methods:
		                        			A literature search on the economic evaluation of thyroid cancer treatment was conducted using the MEDLINE database up to May 2021. Data on population, intervention, comparison, outcome, time, setting, and study design were extracted from each study. The economic evaluation method in each study was re-classified according to the theoretical criteria defined by the international economic evaluation guidelines.  
		                        		
		                        			Results:
		                        			A total of 49 studies were included, involving cost analysis (CA, n=9), cost-minimization analysis (CMA, n=3), cost-effectiveness analysis (CEA, n=29), and cost-utility analysis (CUA, n=8). When CEA and CUA were classified as one method, the consistency between the methods of the reviewers based on the theoretical criteria and those from the original studies was 77% (95% confidence interval, 0.63-0.92). Most studies dealt with specific period-related controversial issues including comparison between treatment strategies, and cost-effectiveness of the prophylactic central neck dissection, molecular testing, and rhTSH. Contrasting results have been obtained when different economic evaluation methods were applied for the same topic (e.g., total thyroidectomy [TT] was more dominant than hemithyroidectomy [HT] in CEA, but HT was more dominant than TT in CUA), and different clinical and economic inputs were applied. All studies included direct medical costs, which were mostly derived from Medicare and input probabilities in each economic model, and utility scores for outcomes were mostly based on literature reviews.Few studies included non-medical direct costs and indirect costs.  
		                        		
		                        			Conclusion
		                        			Our systematic review provides information on how to design and proceed to overcome the limitations of existing studies and ensure validity. 
		                        		
		                        		
		                        		
		                        	
2.A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
Eun Kyung LEE ; Yea Eun KANG ; Young Joo PARK ; Bon Seok KOO ; Ki-Wook CHUNG ; Eu Jeong KU ; Ho-Ryun WON ; Won Sang YOO ; Eonju JEON ; Se Hyun PAEK ; Yong Sang LEE ; Dong Mee LIM ; Yong Joon SUH ; Ha Kyoung PARK ; Hyo-Jeong KIM ; Bo Hyun KIM ; Mijin KIM ; Sun Wook KIM ; Ka Hee YI ; Sue K. PARK ; Eun-Jae JUNG ; June Young CHOI ; Ja Seong BAE ; Joon Hwa HONG ; Kee-Hyun NAM ; Young Ki LEE ; Hyeong Won YU ; Sujeong GO ; Young Mi KANG ;
Endocrinology and Metabolism 2021;36(3):574-581
		                        		
		                        			Background:
		                        			Postoperative thyroid stimulating hormone (TSH) suppression therapy is recommended for patients with intermediate- and high-risk differentiated thyroid cancer to prevent the recurrence of thyroid cancer. With the recent increase in small thyroid cancer cases, the extent of resection during surgery has generally decreased. Therefore, questions have been raised about the efficacy and long-term side effects of TSH suppression therapy in patients who have undergone a lobectomy. 
		                        		
		                        			Methods:
		                        			This is a multicenter, prospective, randomized, controlled clinical trial in which 2,986 patients with papillary thyroid cancer are randomized into a high-TSH group (intervention) and a low-TSH group (control) after having undergone a lobectomy. The principle of treatment includes a TSH-lowering regimen aimed at TSH levels between 0.3 and 1.99 μIU/mL in the low-TSH group. The high-TSH group targets TSH levels between 2.0 and 7.99 μIU/mL. The dose of levothyroxine will be adjusted at each visit to maintain the target TSH level. The primary outcome is recurrence-free survival, as assessed by neck ultrasound every 6 to 12 months. Secondary endpoints include disease-free survival, overall survival, success rate in reaching the TSH target range, the proportion of patients with major cardiovascular diseases or bone metabolic disease, the quality of life, and medical costs. The follow-up period is 5 years. 
		                        		
		                        			Conclusion
		                        			The results of this trial will contribute to establishing the optimal indication for TSH suppression therapy in low-risk papillary thyroid cancer patients by evaluating the benefit and harm of lowering TSH levels in terms of recurrence, metabolic complications, costs, and quality of life.
		                        		
		                        		
		                        		
		                        	
3.A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
Eun Kyung LEE ; Yea Eun KANG ; Young Joo PARK ; Bon Seok KOO ; Ki-Wook CHUNG ; Eu Jeong KU ; Ho-Ryun WON ; Won Sang YOO ; Eonju JEON ; Se Hyun PAEK ; Yong Sang LEE ; Dong Mee LIM ; Yong Joon SUH ; Ha Kyoung PARK ; Hyo-Jeong KIM ; Bo Hyun KIM ; Mijin KIM ; Sun Wook KIM ; Ka Hee YI ; Sue K. PARK ; Eun-Jae JUNG ; June Young CHOI ; Ja Seong BAE ; Joon Hwa HONG ; Kee-Hyun NAM ; Young Ki LEE ; Hyeong Won YU ; Sujeong GO ; Young Mi KANG ;
Endocrinology and Metabolism 2021;36(3):574-581
		                        		
		                        			Background:
		                        			Postoperative thyroid stimulating hormone (TSH) suppression therapy is recommended for patients with intermediate- and high-risk differentiated thyroid cancer to prevent the recurrence of thyroid cancer. With the recent increase in small thyroid cancer cases, the extent of resection during surgery has generally decreased. Therefore, questions have been raised about the efficacy and long-term side effects of TSH suppression therapy in patients who have undergone a lobectomy. 
		                        		
		                        			Methods:
		                        			This is a multicenter, prospective, randomized, controlled clinical trial in which 2,986 patients with papillary thyroid cancer are randomized into a high-TSH group (intervention) and a low-TSH group (control) after having undergone a lobectomy. The principle of treatment includes a TSH-lowering regimen aimed at TSH levels between 0.3 and 1.99 μIU/mL in the low-TSH group. The high-TSH group targets TSH levels between 2.0 and 7.99 μIU/mL. The dose of levothyroxine will be adjusted at each visit to maintain the target TSH level. The primary outcome is recurrence-free survival, as assessed by neck ultrasound every 6 to 12 months. Secondary endpoints include disease-free survival, overall survival, success rate in reaching the TSH target range, the proportion of patients with major cardiovascular diseases or bone metabolic disease, the quality of life, and medical costs. The follow-up period is 5 years. 
		                        		
		                        			Conclusion
		                        			The results of this trial will contribute to establishing the optimal indication for TSH suppression therapy in low-risk papillary thyroid cancer patients by evaluating the benefit and harm of lowering TSH levels in terms of recurrence, metabolic complications, costs, and quality of life.
		                        		
		                        		
		                        		
		                        	
4.Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity.
Eaum Seok LEE ; Seok Hyun KIM ; Hyun Jin KIM ; Kyung Hee KIM ; Byung Seok LEE ; Bon Jeong KU
Gut and Liver 2017;11(2):276-282
		                        		
		                        			
		                        			BACKGROUND/AIMS: Growth differentiation factor 15 (GDF-15) belongs to the transforming growth factor-β superfamily. GDF-15 is emerging as a biomarker for several diseases. The aim of this study was to determine the clinical performances of GDF-15 for the prediction of liver fibrosis and severity in chronic liver disease. METHODS: The serum GDF-15 levels were examined via enzyme immunoassay in 145 patients with chronic liver disease and 101 healthy individuals. The patients with chronic liver disease consisted of 54 patients with chronic hepatitis, 44 patients with compensated liver cirrhosis, and 47 patients with decompensated liver cirrhosis. RESULTS: Of the patients with chronic liver diseases, the decompensated liver cirrhosis patients had an increased serum GDF-15 (3,483 ng/L) level compared with the patients with compensated liver cirrhosis (1,861 ng/L) and chronic hepatitis (1,232 ng/L). The overall diagnostic accuracies of GDF-15, as determined by the area under the receiver operating characteristic curves, were as follows: chronic hepatitis=0.656 (>574 ng/L, sensitivity, 53.7%; specificity, 79.2%), compensated liver cirrhosis=0.886 (>760 ng/L, sensitivity, 75.6%; specificity, 92.1%), and decompensated liver cirrhosis=0.984 (>869 ng/L, sensitivity, 97.9%; specificity, 94.1%). CONCLUSIONS: This investigation represents the first study to demonstrate the availability of GDF-15 in chronic liver disease. GDF-15 comprised a useful biomarker for the prediction of liver fibrosis and severity in chronic liver disease.
		                        		
		                        		
		                        		
		                        			Biomarkers
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			Growth Differentiation Factor 15*
		                        			;
		                        		
		                        			Hepatitis, Chronic
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoenzyme Techniques
		                        			;
		                        		
		                        			Liver Cirrhosis
		                        			;
		                        		
		                        			Liver Diseases*
		                        			;
		                        		
		                        			Liver*
		                        			;
		                        		
		                        			ROC Curve
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			
		                        		
		                        	
5.Factors Influencing Skin Tolerability to the Rivastigmine Patch in Patients with Alzheimer's Disease.
Hae Ri NA ; Moon Ho PARK ; Sangyun KIM ; Dong Won YANG ; Seong Hye CHOI ; Hyun Duk YANG ; Youngsoon YANG ; Hyun Jeong HAN ; Jung Seok LEE ; Young Chul YOON ; Seong Ho KOH ; Jung Eun KIM ; Bon D KU ; Hee Jin KIM ; Kyung Won PARK ; Eun Joo KIM ; Bora YOON ; Key Jung PARK
Dementia and Neurocognitive Disorders 2015;14(1):31-38
		                        		
		                        			
		                        			BACKGROUND AND PURPOSE: The one-day rivastigmine patch is reportedly well tolerated and has minimal side effects. However, Asian patients show more side effects than those in Western countries. We evaluated tolerability of the rivastigmine patch in South Korean patients with Alzheimer's disease (AD) and the specific factors affecting adverse events of the skin. METHODS: A 6-month, open labeled, multi-centered, observational study was carried out in 440 patients with probable AD from July 2009 to September 2010 (NCT01312363). RESULTS: A total of 25.9% of the patients experienced adverse skin events at the rivastigmine patch application site and 17.0% discontinued treatment due to adverse events at the skin application site. The most common adverse events were itching and erythema. Patients with an allergic history and users of electric heating appliances reported skin discomfort. Older age was associated with discontinuing treatment. CONCLUSION: These results suggest that the rivastigmine patch induced some adverse skin events and may contribute to understanding and improving skin tolerability to the rivastigmine patch.
		                        		
		                        		
		                        		
		                        			Alzheimer Disease*
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Erythema
		                        			;
		                        		
		                        			Heating
		                        			;
		                        		
		                        			Hot Temperature
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Observational Study
		                        			;
		                        		
		                        			Pruritus
		                        			;
		                        		
		                        			Skin*
		                        			;
		                        		
		                        			Rivastigmine
		                        			
		                        		
		                        	
6.Tazarotene-Induced Gene 3 May Affect Inflammatory Angiogenesis in Psoriasis by Downregulating Placental Growth Factor Expression.
Su Young JEON ; Seung Min HA ; Dong Yeob KO ; Bon Seok KU ; Chae Young LEE ; Ki Hoon SONG ; Ki Ho KIM
Annals of Dermatology 2014;26(4):517-520
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Psoriasis*
		                        			
		                        		
		                        	
7.CD4-/CD56+/CD123+ Hematodermic Neoplasm Showing Early Liver Metastasis.
Kyu Won CHOI ; Ki Yeol LEE ; Yeong Kyu LEE ; Bon Seok KU ; Hong Seok KIM ; Young Hun KIM ; Ki Ho KIM
Annals of Dermatology 2010;22(2):186-190
		                        		
		                        			
		                        			Hematodermic neoplasm (HN) is a clinically aggressive neoplasm with a high incidence of cutaneous involvement and a risk of leukemic dissemination. In the recent WHO-EORTC classification, the term blastic natural killer cell lymphoma has been replaced with CD4+/CD56+ HN because of its derivation from a plasmacytoid dendritic cell precursor. Cases of HN that completely lack CD4 or CD56 expression, therefore represents a diagnostic problem. A 68-year-old Korean male was diagnosed with CD4-/CD56+ HN and treated with hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, dexamethasone) at initial treatment, and then switched to high dose methotrexate/cytarabine. His disease relapsed and resulted in death from bone and brain disease 6 months after complete clinical remission, despite diagnostic workups, including a radioisotope liver scan and ultrasound-guided fine needle aspiration biopsy. Further cytogenetic studies such as comparative genomic hybridization could elucidate the genetic mechanisms in the development and progression of lymphomas. We report an unusual case of 'CD4-/CD56+/CD123+ HN' showing early liver metastasis.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Biopsy, Fine-Needle
		                        			;
		                        		
		                        			Brain Diseases
		                        			;
		                        		
		                        			Comparative Genomic Hybridization
		                        			;
		                        		
		                        			Cytogenetics
		                        			;
		                        		
		                        			Dendritic Cells
		                        			;
		                        		
		                        			Doxorubicin
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Killer Cells, Natural
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Lymphoma
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Vincristine
		                        			
		                        		
		                        	
8.A Case of Constrictive Pericarditis Associated With Huge Epicardial Fat Volume.
Gi Won DO ; Bon Seung KU ; Chan Sung PARK ; Shin Jae KIM ; Eun Seok SHIN ; Seong Hoon CHOI ; Sang Gon LEE
Korean Circulation Journal 2009;39(3):116-120
		                        		
		                        			
		                        			Massive deposits of fat around heart are seen in overweight persons and are associated with coronary artery disease. Investigators have focused on the clinical significance of epicardial fat with respect to metabolic effects such as insulin resistance and inflammation, but the mechanical effects, such as constriction, have been largely ignored. We present an unusual case of a 59-year-old woman with obesity and diabetes mellitus who had been undergoing peritoneal dialysis due to end-stage renal disease, and who developed constrictive pericarditis, possibly secondary to extensive epicardial fatty accumulation.
		                        		
		                        		
		                        		
		                        			Cardiac Catheterization
		                        			;
		                        		
		                        			Constriction
		                        			;
		                        		
		                        			Coronary Artery Disease
		                        			;
		                        		
		                        			Diabetes Mellitus
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Heart
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Insulin Resistance
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Obesity
		                        			;
		                        		
		                        			Overweight
		                        			;
		                        		
		                        			Pericarditis, Constrictive
		                        			;
		                        		
		                        			Pericardium
		                        			;
		                        		
		                        			Peritoneal Dialysis
		                        			;
		                        		
		                        			Research Personnel
		                        			;
		                        		
		                        			Tomography, Spiral Computed
		                        			
		                        		
		                        	
9.Systematic Evaluation on the Quantitative and Qualitative Aspects of Korean Nutrition Education Websites.
Hong Seok AHN ; Bon Suk KU ; Seungmin LEE
Journal of the Korean Dietetic Association 2008;14(3):218-228
		                        		
		                        			
		                        			This study was conducted to evaluate the quantitative and qualitative aspects of Korean websites related to nutrition education. A total of 30 websites were ultimately selected through 4 major Internet search engines, including Naver, Yahoo, Daum, and Nate, using several key words (i.e., nutrition education, dietary life education, nutrition information, nutrition management, etc.). A systematic review was conducted for each of the selected websites based on the American Library Association (ALA) website checklist and a data abstract form that was adapted from a previous study. Approximately two thirds of the websites were established between 2002 and 2005, and 46.6% were administrated by public health centers or schools/colleges. The most frequently targeted group was the generally healthy population (30.0%). Among the various topics of nutrition information provided, "balanced diet" was the topic most often provided by the websites. Also, an increasing trend for utilizing multimedia tools was observed; however, little technical support or instruction was provided by the websites. Only 50.0% and 63.3% of the sites clearly stated their operators and sources of provided information, respectively. Overall, the purposes of sites were clearly stated, and were not overshadowed by advertising. And most features of design, stability, and content were found to be appropriate, but several aspects, such as establishing a help/FAQ menu, regularly updating nutrition information, and converting provided information into a database for easier search and update, needed improvement. In addition, active operational strategies are greatly needed to encourage the application of materials found on sites into real educational settings.
		                        		
		                        		
		                        		
		                        			Checklist
		                        			;
		                        		
		                        			Internet
		                        			;
		                        		
		                        			Library Associations
		                        			;
		                        		
		                        			Multimedia
		                        			;
		                        		
		                        			Public Health
		                        			;
		                        		
		                        			Search Engine
		                        			
		                        		
		                        	
10.Angiomatoid Spitz Nevus.
Oh Eon KWON ; Bon Seok KU ; Yeong Kyu LEE ; Young Hun KIM ; Ki Ho KIM
Annals of Dermatology 2008;20(1):14-17
		                        		
		                        			
		                        			Spitz nevus is a variant of melanocytic nevus which is histopathologically defined as large spindle and/or epithelioid cells. Angiomatoid Spitz nevus is a rare histologic variant of desmoplastic Spitz nevus characterized by prominent vasculature. We present a case of angiomatoid Spitz nevus, celluar type, that has not been reported before. We provide another example to show the remarkable diversity of Spitz nevus.
		                        		
		                        		
		                        		
		                        			Epithelioid Cells
		                        			;
		                        		
		                        			Nevus, Epithelioid and Spindle Cell
		                        			;
		                        		
		                        			Nevus, Pigmented
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail